MaryBerylDalyMD

Oncology • Philadelphia, PA

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Clinical Professor of Medicine, Temple University

Join to view full profile

Dr. Daly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Daly's full profile

Already have an account?

Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111
Phone+1 215-728-6900

Fax+1 215-214-3999

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1978 - 1981
University of North Carolina at Chapel Hill School of MedicineClass of 1978

Certifications & Licensure

TX State Medical License 1980 - 2026
NJ State Medical License 1999 - 2025
PA State Medical License 1989 - 2024
NC State Medical License 1979 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
Philadelphia Magazine Castle Connolly, 2005-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk Start of enrollment: 2002 Sep 01
Terminated
Not Applicable
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Efficacy of a couple-based intervention addressing sexual concerns for breast cancer survivors: Results of a randomized controlled trial.
Jennifer Barsky Reese, Stephen J Lepore, Kristen A Sorice, Lauren A Zimmaro, Jill Hasler
Cancer. 2024-12-08
Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk.
Robert J Macinnis, Mark A Jenkins, Roger L Milne, Esther M John, Mary B Daly
JNCI Cancer Spectrum. 2024-12-03
Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years.
Rebecca D Kehm, Jeanine M Genkinger, Julia A Knight, Robert J Maclnnis, Yuyan Liao
Cancer Epidemiology, Biomarkers & Prevention. 2024-10-15

Journal Articles

Association of Risk-Reducing Salpingo-Oophorectomy with Breast Cancer Risk in Women with BRCA1 and BRCA2 Pathogenic Variants
Mary B Daly, Sarah Colonna, Saundra S Buys, Allison W Kurian, JAMA Oncology

Lectures

Scientific and Clinical Update in Gynecologic Oncology
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 5/3/2013

Press Mentions

NCCN Announces Expanded Practice Guidelines for Breast Cancer with Hereditary RisksDecember 13th, 2024
NCCN Issues Updated Guidance on Genetic Testing for Several CancersNovember 25th, 2024
NCCN’s Cancer Care Guidelines Expanded to Include More Hereditary RisksNovember 12th, 2024
Join now to see all

Grant Support

Legacy: A Cohort Of Youth In Families From The Breast Cancer Family RegistryNational Cancer Institute2011–2012
Improving The Estimation And Communication Of Ovarian Cancer Risk Among BRCA1/2 CNational Cancer Institute2009–2011
Personalized Medicine: Understanding And Utilization By Health Care ProvidersNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
Philadelphia Breast Cancer Family RegistryNational Cancer Institute2006–2010
Facilitating Web-Based Patient Decision Support For Hereditary Breast Cancer RiskNational Institute Of Nursing Research2009
Benign Breast Disease: A New Frontier For PreventionNational Cancer Institute2005–2009
Communicating Genetic Test Results To The FamilyNational Cancer Institute1999–2008
Cooperative Family Registry For Breast Cancer StudyNational Cancer Institute2001–2006
Advanced Cancer Risk Counseling Training For NursesNational Cancer Institute1998–2006
Benign Breast Registry To Assess Valid EndpointsNational Cancer Institute2004–2005
Participation In A Family Based Cancer RegistryNational Cancer Institute2001–2002
Core--MaintenanceNational Cancer Institute2001–2002
Core--Ovarian Cancer Clinical NetworkNational Cancer Institute1999–2002
Comprehensive Familial Breast Cancer RegistryNational Cancer Institute1995–2000
Training Nurse For Familial Cancer Risk CounselingNational Cancer Institute1995–1997
Involving African American Women In Breast Cancer TrialsNational Cancer Institute1995–1996
Interactive Multimedia In Breast Cancer Risk EducationNational Cancer Institute1995–1996
Coping With Genetic Risk For Breast And Ovarian CancerNational Human Genome Research Institute1994–1996
Minority High School Student Research Apprentice ProgramNational Center For Research Resources1994–1995